Functional variations between Mesenchymal Stem Cells of different tissue origins: A comparative gene expression...

Area of Science:

• Regenerative Medicine
• Cell Biology
• Immunology

Background:

• Mesenchymal Stem Cells (MSCs) are crucial for cellular therapy due to their immune-privileged nature and regenerative capabilities.
• Understanding MSC biological functions from various sources is vital for effective therapeutic applications.

Purpose of the Study:

• To characterize variations in multipotent functions of MSCs from fetal (Wharton's jelly, placental) and adult (bone marrow, adipose tissue) sources.
• To compare cell surface antigen levels, proliferation, differentiation, and stemness potential using gene expression analysis.

Main Methods:

• Isolation and culture of MSCs from five different tissue sources: Wharton's jelly (WJ), fetal placenta (PF), maternal placenta (PM), bone marrow (BM), and adipose tissue (AT).
• Quantitative real-time PCR (qRT-PCR) was used to analyze gene expression related to cell surface markers, proliferation, differentiation, and stemness.
• Growth curve analysis and PCNA/Wnt gene expression were used to assess proliferation potential.

Main Results:

• Maternal placenta (PM), fetal placenta (PF), and adipose tissue (AT) MSCs showed significantly increased CD73 expression, suggesting immunomodulatory roles.
• Wharton's jelly (WJ) MSCs demonstrated superior proliferation potential.
• Bone marrow (BM) MSCs exhibited superior trilineage differentiation capabilities.
• Enhanced stemness potential (Oct 4, Nanog) was observed in both BM and WJ MSCs, which also expressed high CD90 levels, indicating suitability for bone repair.

Conclusions:

• Bone marrow (BM) and Wharton's jelly (WJ) derived MSCs are superior candidates for cell repair and regeneration studies.
• These findings highlight the importance of source selection for optimizing MSC-based therapies.